Transposition-mediated identification of specific binding or functional proteins
AssigneeNbe-Therapeutics AG
InventorUlf Grawunder
Life of this patent
Estimating the term…
Loading patent…
AssigneeNbe-Therapeutics AG
InventorUlf Grawunder
Estimating the term…
The method disclosed herein describes a novel technology offering unparalleled efficiency, flexibility, utility and speed for the discovery and optimization of polypeptides having desired binding specificity and/or functionality, including antigen-binding molecules such as antibodies and fragments thereof, for desired functional and/or binding phenotypes. The novel method is based on transposable constructs and diverse DNA libraries cloned into transposable vectors and their transfection into host cells by concomitant transient expression of a functional transposase enzyme. This ensures an efficient, stable introduction of the transposon-based expression vectors into vertebrate host cells in one step, which can then be screened for a desired functional or binding phenotype of the expressed proteins, after which the relevant coding sequences for the expressed proteins, including antibodies and fragments thereof, can be identified by standard cloning and DNA sequencing techniques.
1-20. (canceled)
A method of obtaining a polypeptide having a desired binding specificity or functionality, comprising:
30-34. (canceled)
A vector or set of vectors, comprising a sequence encoding a VH or VL region of an antibody, or antigen-binding portion thereof, disposed between inverted terminal repeat sequences that are recognized by and functional with at least one transposase enzyme.
45-47. (canceled)
A method for generating a population of host cells capable of expressing polypeptides having different binding specificities or functionalities, comprising:
Dependencies are inferred from the claim text.